{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T14:27:13Z","timestamp":1789396033656,"version":"build-2803163510"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"The National Key Technology Research and Development Program of the Ministry of Science and Technology of China","award":["2014BAI04B01"],"award-info":[{"award-number":["2014BAI04B01"]}]},{"name":"The National Key Technology Research and Development Program of the Ministry of Science and Technology of China","award":["2015BAI12B04"],"award-info":[{"award-number":["2015BAI12B04"]}]},{"DOI":"10.13039\/501100009331","name":"Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support","doi-asserted-by":"crossref","award":["ZYLX201608"],"award-info":[{"award-number":["ZYLX201608"]}],"id":[{"id":"10.13039\/501100009331","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004826","name":"Beijing Municipal Natural Science Foundation","doi-asserted-by":"publisher","award":["7161004"],"award-info":[{"award-number":["7161004"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jocn-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.jocn.2017.09.014","type":"journal-article","created":{"date-parts":[[2017,10,5]],"date-time":"2017-10-05T04:31:27Z","timestamp":1507177887000},"page":"50-57","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["BRAF V600E mutation is a significant prognosticator of the tumour regrowth rate in brainstem gangliogliomas"],"prefix":"10.1016","volume":"46","author":[{"given":"Xin","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changcun","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuliang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yibo","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengcheng","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.jocn.2017.09.014_b0005","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1177\/0883073808319316","article-title":"Brainstem ganglioglioma","volume":"23","author":"Mpairamidis","year":"2008","journal-title":"J Child Neurol"},{"issue":"12","key":"10.1016\/j.jocn.2017.09.014_b0010","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1136\/jnnp.57.12.1497","article-title":"Gangliogliomas: clinical, radiological, and histopathological findings in 51 patients","volume":"57","author":"Zentner","year":"1994","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"10.1016\/j.jocn.2017.09.014_b0015","doi-asserted-by":"crossref","first-page":"867","DOI":"10.3171\/jns.1993.79.6.0867","article-title":"Central nervous system gangliogliomas. part 2: clinical outcome","volume":"79","author":"Lang","year":"1993","journal-title":"J Neurosurg"},{"issue":"2","key":"10.1016\/j.jocn.2017.09.014_b0020","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3171\/jns.1984.60.2.0431","article-title":"Ganglioglioma of the brain stem: case report","volume":"60","author":"Garcia","year":"1984","journal-title":"J Neurosurg"},{"issue":"3","key":"10.1016\/j.jocn.2017.09.014_b0025","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s11060-016-2131-z","article-title":"Brainstem gangliogliomas: prognostic factors, surgical indications and functional outcomes","volume":"128","author":"Pan","year":"2016","journal-title":"J Neurooncol"},{"issue":"6892","key":"10.1016\/j.jocn.2017.09.014_b0030","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature00766","article-title":"Mutations of the BRAF gene in human cancer","volume":"417","author":"Davies","year":"2002","journal-title":"Nature"},{"issue":"24","key":"10.1016\/j.jocn.2017.09.014_b0035","doi-asserted-by":"crossref","first-page":"7595","DOI":"10.1158\/1078-0432.CCR-11-1456","article-title":"Targeted therapy for BRAFV600E malignant astrocytoma","volume":"17","author":"Nicolaides","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.jocn.2017.09.014_b0040","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00401-004-0936-x","article-title":"Mutation analysis of BRAF gene in human gliomas","volume":"109","author":"Basto","year":"2005","journal-title":"Acta Neuropathol"},{"issue":"7","key":"10.1016\/j.jocn.2017.09.014_b0045","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1093\/neuonc\/noq007","article-title":"Activating mutations in braf characterize a spectrum of pediatric low-grade gliomas","volume":"12","author":"Dougherty","year":"2010","journal-title":"Neuro Oncol"},{"issue":"2","key":"10.1016\/j.jocn.2017.09.014_b0050","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/bpa.12103","article-title":"Pediatric brainstem gangliogliomas show BRAF V600E mutation in a high percentage of cases","volume":"24","author":"Donson","year":"2014","journal-title":"Brain Pathol"},{"issue":"11","key":"10.1016\/j.jocn.2017.09.014_b0055","doi-asserted-by":"crossref","first-page":"3590","DOI":"10.1158\/1078-0432.CCR-10-3349","article-title":"BRAF activation induces transformation and then senescence in human neural stem cells: a pilocytic astrocytoma model","volume":"17","author":"Raabe","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.jocn.2017.09.014_b0060","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/pbc.25787","article-title":"Successful retreatment of a child with a refractory brainstem ganglioglioma with Vemurafenib","volume":"63","author":"Aguilera","year":"2015","journal-title":"Pediatr Blood Cancer"},{"issue":"14","key":"10.1016\/j.jocn.2017.09.014_b0065","doi-asserted-by":"crossref","first-page":"4650","DOI":"10.1158\/1078-0432.CCR-11-0127","article-title":"Genetic aberrations leading to MAPK pathway activation mediate oncogene-induced senescence in sporadic pilocytic astrocytomas","volume":"17","author":"Jacob","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.jocn.2017.09.014_b0070","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1172\/JCI44656","article-title":"An activated mutant BRAF kinase domain is sufficient to induce pilocytic astrocytoma in mice","volume":"121","author":"Gronych","year":"2011","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.jocn.2017.09.014_b0075","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/neuonc\/nos077","article-title":"Interplay among BRAF, p16, p53, and MIB1 in pediatric low-grade gliomas","volume":"14","author":"Horbinski","year":"2012","journal-title":"Neuro Oncol"},{"issue":"11","key":"10.1016\/j.jocn.2017.09.014_b0080","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1200\/JCO.2009.26.3541","article-title":"Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncologyworking group","volume":"28","author":"Wen","year":"2010","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.jocn.2017.09.014_b0085","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.mri.2012.05.001","article-title":"3D Slicer as an image computing platform for the quantitative imaging network","volume":"30","author":"Fedorov","year":"2012","journal-title":"Magn Reson Imaging"},{"issue":"4","key":"10.1016\/j.jocn.2017.09.014_b0090","doi-asserted-by":"crossref","first-page":"884","DOI":"10.3171\/2013.1.JNS121323","article-title":"Brainstem gangliogliomas: a retrospective series","volume":"118","author":"Zhang","year":"2013","journal-title":"J Neurosurg"},{"issue":"5","key":"10.1016\/j.jocn.2017.09.014_b0095","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0090-3019(01)00618-8","article-title":"Ganglioglioma of the brainstem: report of three cases and review of the literature","volume":"56","author":"Lagares","year":"2001","journal-title":"Surg Neurol"},{"issue":"14","key":"10.1016\/j.jocn.2017.09.014_b0100","first-page":"3883","article-title":"BRAF oncogenic mutations correlate with progression rather than initiation of human melanoma","volume":"63","author":"Dong","year":"2003","journal-title":"Cancer Res"},{"issue":"5","key":"10.1016\/j.jocn.2017.09.014_b0105","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1172\/JCI33656","article-title":"BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas","volume":"118","author":"Pfister","year":"2008","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.jocn.2017.09.014_b0110","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/pbc.24891","article-title":"Vemurafenib in pediatric patients with BRAF V600E, mutated high-grade gliomas","volume":"61","author":"Bautista","year":"2014","journal-title":"Pediatr Blood Cancer"},{"issue":"9","key":"10.1016\/j.jocn.2017.09.014_b0115","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1200\/JCO.2014.58.3922","article-title":"BRAF mutation and CDKN2A deletion define a clinically distinct subgroup of childhood secondary high-grade glioma","volume":"33","author":"Mistry","year":"2015","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.jocn.2017.09.014_b0120","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00401-013-1120-y","article-title":"BRAF(V600E) mutation is a negative prognosticator in pediatric ganglioglioma","volume":"125","author":"Dahiya","year":"2013","journal-title":"Acta Neuropathol"},{"issue":"2","key":"10.1016\/j.jocn.2017.09.014_b0125","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1023\/A:1019661528350","article-title":"Intracranial ganglioglioma: preoperative characteristics and oncologic outcome after surgery","volume":"59","author":"Im","year":"2002","journal-title":"J Neurooncol"},{"issue":"1","key":"10.1016\/j.jocn.2017.09.014_b0130","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1023\/B:NEON.0000024747.66993.26","article-title":"Spinal cord gangliogliomas: a review of 56 patients","volume":"68","author":"Jallo","year":"2004","journal-title":"J Neurooncol"},{"issue":"1","key":"10.1016\/j.jocn.2017.09.014_b0135","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2217\/cns.15.40","article-title":"Recurrent ganglioglioma in adults treated with BRAF inhibitors","volume":"5","author":"Chamberlain","year":"2016","journal-title":"CNS Oncol"},{"issue":"11","key":"10.1016\/j.jocn.2017.09.014_b0140","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.6004\/jnccn.2016.0145","article-title":"Personalized treatment for a patient with a BRAF V600E mutation using Dabrafenib and a tumor treatment fields device in a high-grade glioma arising from ganglioglioma","volume":"14","author":"Meletath","year":"2016","journal-title":"J Natl Compr Canc Netw"},{"issue":"10","key":"10.1016\/j.jocn.2017.09.014_b0145","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1200\/JCO.2012.44.1568","article-title":"Brainstem ganglioglioma successfully treated with Vemurafenib","volume":"31","author":"Rush","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jocn.2017.09.014_b0150","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1186\/s12967-014-0356-1","article-title":"Response of recurrent BRAFV600E mutated ganglioglioma to Vemurafenib as single agent","volume":"12","author":"del Bufalo","year":"2013","journal-title":"J Transl Med"},{"key":"10.1016\/j.jocn.2017.09.014_b0155","article-title":"Co-occurrence of histone H3 K27M and BRAF V600E mutations in paediatric midline grade I ganglioglioma","author":"Pag\u00e8s","year":"2016","journal-title":"Brain Pathol"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586817301819?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586817301819?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T09:08:00Z","timestamp":1589792880000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586817301819"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":31,"alternative-id":["S0967586817301819"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2017.09.014","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BRAF V600E mutation is a significant prognosticator of the tumour regrowth rate in brainstem gangliogliomas","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2017.09.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}